Prenatal Dexamethasone Treatment of Congenital Adrenal Hyperplasia: Are We Any Closer to Considering It Safe?

J Clin Endocrinol Metab. 2022 Dec 17;108(1):e9-e10. doi: 10.1210/clinem/dgac524.

Authors

Margaret de Castro¹, Clarissa Silva Martins^{1

2}, Sonir R Antonini³

Affiliations

¹ Department of Internal Medicine of Ribeirao Preto Medical School, University of São Paulo, 14049-900 Ribeirao Preto, São Paulo, Brazil.
² Faculty of Medicine, Federal University of Mato Grosso do Sul, 79070-900, Campo Grande, Mato Grosso do Sul, Brazil.
³ Department of Pediatrics of Ribeirao Preto Medical School, University of São Paulo, 14049-900 Ribeirao Preto, São Paulo, Brazil.

PMID: 36101901
DOI: 10.1210/clinem/dgac524

No abstract available

Keywords: brain function; congenital adrenal hyperplasia; prenatal dexamethasone treatment.

Publication types

Editorial
Comment

MeSH terms

Adolescent
Adrenal Hyperplasia, Congenital* / complications
Adrenal Hyperplasia, Congenital* / drug therapy
Adult
Dexamethasone / adverse effects
Female
Humans
Pregnancy
Pregnancy Trimester, First
Virilism

Substances

Dexamethasone